Tari Ao Whānui

I te 25 o Paenga-whāwhā, 2025, i panuitia e InnoCare Pharma kua whakaaetia te arotake matua mō tana aukati pan-TRK hou zurletrectinib (ICP-723) e te Center for Drug Assessment (CDE) o te China National Medical Products Administration (NMPA), i whakaae ki te New Drug Application (NDA) o z...Pānuihia atu»

I te 25 o Paenga-whāwhā, 2025, ka panuitia e Innovent Biologics kua whakaaetia e te Whakahaere Hua Hauora ā-Motu o Haina (NMPA) te Tono Rongoā Hou (NDA) mō te limertinib hei maimoatanga raina tuatahi mō ngā tūroro pakeke e pangia ana e te mate pukupuku pūkahukahu kore-pūtau iti (NSCLC) kua horapa ki te rohe, kua horapa rānei...Pānuihia atu»

I te 23 o Paenga-whāwhā, i whakaaetia te penpulimab a Akeso e te Food and Drug Administration me te cisplatin, carboplatin rānei me te gemcitabine hei rongoā tuatahi mō ngā pakeke e pāngia ana e te mate pukupuku nasopharyngeal non-keratinizing (NPC) e hokihoki mai ana, e horapa mai ana rānei. I whakaaetia hoki e te FDA te penpulimab-kcqx hei rongoā hara...Pānuihia atu»

I te 16 o Poutū-te-rangi, 2025, i panuitia e Akeso kua whakaaetia mana e te National Medical Products Administration (NMPA) tana paturopi monoclonal anti-PD-1 auaha, i whakawhanakehia e ia anō, ko te penpulimab, hei rongoā tuatahi mō te mate pukupuku nasopharyngeal (NPC) e hokihoki mai ana, e horapa ana rānei, i te whakakotahitanga o ...Pānuihia atu»

I te 24 o Paenga-whāwhā, 2025, i panuitia e GenFleet Therapeutics kua whakaaetia e te US Food and Drug Administration (FDA) te tono rongoā hou (IND) o te GFH375/VS-7375, he aukati KRAS G12D (ON/OFF) ā-waha, mō te whakamātautau haumanu e rongoā ana i ngā tūroro pukupuku totoka matatau e mau ana i te whakarerekētanga KRAS G12D. Ko te rangahau...Pānuihia atu»

I te 17 o Paenga-whāwhā, 2025, i panuitia e Hansoh Pharmaceutical kua whakaaetia te werohanga HS-20093 i whakawhanakehia e te Rōpū hei rongoā Breakthrough-Therapy-Tohu e te National Medical Products Administration (NMPA) o Haina, ...Pānuihia atu»

I te 15 o Paenga-whāwhā, 2025, i panuitia e InnoCare Pharma kua whakaaetia e te Center for Drug Assessment (CDE) o te China National Medical Products Administration (NMPA) tētahi Tono Rongoā Hou (NDA) mō tana inhibitor pan-TRK whakatupuranga hou zurletrectinib (ICP-723) mō te maimoatanga o ngā pakeke me ngā taiohi p...Pānuihia atu»

Nō nā tata nei, i panuitia e GenFleet ngā raraunga wāhanga II hou o te rangahau KROCUS, fulzerasib (GFH925, KRAS G12C inhibitor) me te cetuximab mō te maimoatanga tuatahi o te mate pukupuku pūkahukahu kore-pūtau iti (NSCLC), i roto i tētahi whakarāpopototanga poto i te whakaaturanga ā-waha poto o te Huihuinga Mate Pukupuku Pūkahukahu Pākehā 2025...Pānuihia atu»

Ko te PLB1004, i whakawhanakehia e Beijing Avistone Biotechnology Co., Ltd., he rongoā haumaru, he tino whiriwhiri, he whai hua hoki hei aukati i te tipu epidermal growth factor receptor tyrosine kinase (EGFR-TKI) e whakamahia ana hei rongoā i te mate pukupuku pūkahukahu kore-pūtau-iti (NSCLC). I te 9 o Paenga-whāwhā, 2025, i whakahaerehia e te National Medical Products Admi...Pānuihia atu»

I te 13 o Poutū-te-rangi, 2025, i whakaputaina e te hautaka o te ao rongonui, Nature Medicine, te whakamātautau a MediLink mō te B7-H3 e aro ana ki te rongoā paturopi (ADC) YL201 Wāhanga 1/1b. I whakaurua ki te whakamātautau he wāhanga whakanui horopeta (wāhanga 1) me te wāhanga whakawhānui horopeta (wāhanga 1b). E 312 ngā tūroro katoa i whakaurua puta noa i...Pānuihia atu»

I te 21 o Poutū-te-rangi, 2025, i panuitia e Immunofoco kua whakaaetia tana rongoā pūtau CAR-T autologous EpCAM-targeting motuhake, IMC001, e te Center for Drug Evaluation (CDE) i raro i te National Medical Products Administration (NMPA) i Haina mō tana tuarua o ngā Rangahau Hou...Pānuihia atu»

I te 31 o Poutū-te-rangi, 2025, i panuitia e Innovent Biologics kua whakawhiwhia e te Center for Drug Assessment (CDE) o te National Medical Products Administration (NMPA) te Breakthrough Therapy Designation (BTD) mō te IBI363, he pūmua whakakotahitanga paturopi PD-1/IL-2α-bias bispecific tuatahi o te karaehe, hei monotherapy mō...Pānuihia atu»